CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 74% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Angle PLC (LSE: AGL) is a UK-based liquid biopsy company developing Parsortix®, a platform for capturing circulating tumour cells (CTCs) in blood. Its technology enables early cancer detection and personalised treatment. With applications across oncology diagnostics and research, Angle supports the shift toward non-invasive precision medicine.
Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.